Cutler Group LP Obs Eva Sa Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$1.99 - $3.1 $5,369 - $8,363	-2,698 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$2.47 - $3.34 $247 - $334	100 Added 3.85%	2,698 $8,000
Q2 2021 Jul 19, 2021	SELL	$2.56 - $3.35 $5,637 - $7,376	-2,202 Reduced 45.88%	2,598 $7,000
Q4 2020 Jan 21, 2021	BUY	$1.89 - $2.55 $8,505 - $11,475	4,500 Added 1500.0%	4,800 $9,000
Q3 2020 Oct 27, 2020	BUY	$2.46 - $6.15 $738 - $1,845	300 New	300 $0

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.